Finance

Lists
Q3 2026 earnings • released • EPS beat +14.91% • Revenue beat +1.43%
See results
INMD:NASDAQ
Inmode Ltd
$13.27
+0.61%
(+0.080) 1D
$13.25
-0.15% (-0.020)
After hours
Closed: Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for INMD...
Open
$13.16
High
$13.30
Low
$13.04
Mkt. cap
763.61M
Avg. vol.
565.46K
Volume
566.37K
P/E ratio
10.96
52-wk high
$16.67
52-wk low
$12.72
EPS
$1.21
Beta
1.98
Shares outstanding
57.48M
No. of employees
660
Open
$13.16
High
$13.30
Low
$13.04
Mkt. cap
763.61M
Avg. vol.
565.46K
Volume
566.37K
P/E ratio
10.96
52-wk high
$16.67
52-wk low
$12.72
EPS
$1.21
Beta
1.98
Shares outstanding
57.48M
No. of employees
660
News stories
From web sources and news partners
About Inmode Ltd
CEOMoshe Mizrahy
Employees660
Founded2008
Headquarters-
SectorHealth Care
IndustryMedical device
Websiteinmodemd.com
Analyst ratings
Based on 3 analysts giving stock ratings to INMD in the past 3 months
Hold
Buy
0
Hold
3
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for INMD in the last 3 months.
Highest
Current $13.27
$15.00 (+13.04%)
Average
$15.00 (+13.04%)
Lowest
$15.00 (+13.04%)
Analyst
Recommendation
Action
Price target
Projected
Date
Caitlin Roberts
Canaccord Genuity
Hold
Maintained
$15.00
+13%
11/13/2026
Jeff Johnson
Robert W. Baird
Hold
Maintained
$15.00
+13%
11/12/2026
Sam Eiber
BTIG
Hold
Reiterated
-
-
11/11/2026
Michael Matson
Needham
Hold
Maintained
-
-
08/05/2026
Matt Miksic
Barclays
Buy
Maintained
$19.00
+43.2%
05/07/2026
Unknown Analyst
Jefferies
Hold
Reiterated
$15.00
+13%
04/14/2026
Last report
Nov 11, 2026
Fiscal period
Q3 2026
$0.37 / $0.32
+14.91%beat
Revenue / Est. (USD)
92.14M / 90.84M
+1.43%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
103.85M
82.02M
95.59M
92.14M
Cost of goods sold
22.55M
20.46M
24.07M
20.34M
Cost of revenue
22.55M
20.46M
24.07M
20.34M
Research and development expenses
3.51M
3.54M
3.66M
3.86M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
51.80M
47.95M
55.60M
50.42M
Operating expense
55.31M
51.50M
59.26M
54.29M
Total operating expenses
77.86M
71.96M
83.33M
74.63M
Operating income
25.99M
10.06M
12.26M
17.51M
Other non operating income
3.38M
-
-
4.71M
EBT including unusual items
31.29M
14.35M
19.69M
22.22M
EBT excluding unusual items
31.31M
14.35M
19.69M
22.22M
Income tax expense
4.27M
2.79M
2.62M
3.36M
Effective tax rate
13.64%
19.44%
13.33%
15.10%
Other operating expenses
-
-
-
-
Net income
27.02M
11.56M
17.06M
18.86M
Net profit margin
26.02%
14.10%
17.85%
20.47%
Earnings per share
0.46
0.25
0.35
0.37
Interest and investment income
1.94M
4.30M
7.43M
-
Interest expense
-
-
-
-
Net interest expenses
1.94M
4.30M
7.43M
-
Depreciation and amortization charges
-
-
-
-
EBITDA
26.16M
10.23M
12.44M
17.74M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps